Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
0.695USD
-0.036-4.92%
Market hours 09/24, 15:07（ET）
128.77MMarket Cap
LossP/E TTM
Neumora Therapeutics Inc (NMRA) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Neumora Therapeutics Inc in the past month.
Buy
3 Strong Buy
4 Buy
1 Hold
1 Sell
0 Strong Sell
Target Price
6.143USD+689.06%
NMRA Analyst Recommendation Trends
In the current month, NMRA has received 4 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. NMRA average Analyst price target in the last month is 6.143.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
2
4
4
4
4
4
4
4
4
1
1
1
1
1
1
1
2
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
9
9
9
9
9
9
9
9
Financial Forecasting
Based on analysts' estimates, NMRA EPS is projected to reach -0.197 in FY2026Q3, following reported EPS of -0.233 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.33
-0.31
-0.24
-0.20
-0.18
Actual
-0.35
-0.30
-0.23
--
--
Surprise
-8.32%
+4.13%
+3.05%
--
--
FAQs
What is Neumora Therapeutics Inc's price target?
Analysts forecast that Neumora Therapeutics Inc's price target is USD 5.00, with the highest forecast at USD 18.00 and the lowest forecast at USD 2.00.
How have Neumora Therapeutics IncNMRA's recent earnings per share performed?
The market expectation was USD -0.23, while Neumora Therapeutics IncNMRA's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Neumora Therapeutics Inc?
Based on the ratings of Neumora Therapeutics Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.